Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says The company discontinued developing emugrobart after two studies showed the drug didn’t achieve intended outcomes. Post navigation Previous Previous post: Record-setting Big Mac eater underwhelmed by McDonald’s new Big Arch burgerNext Next post: Mixing AI And The Military Can Be Dangerous – This Proposed Bill Might Help Leave a Reply Cancel replyYour email address will not be published. Required fields are marked *Comment * Name * Email * Website Save my name, email, and website in this browser for the next time I comment. Related News Who Owns the Future of AI? 0 Fujifilm’s X Half is even more whimsical with a $300 price cut 0
